Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Short Interest Update

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 4,600 shares, a decrease of 82.4% from the August 15th total of 26,100 shares. Based on an average daily trading volume, of 220,200 shares, the days-to-cover ratio is presently 0.0 days.

OTCMKTS SNPHY traded down $0.28 during trading on Wednesday, hitting $15.23. The company had a trading volume of 13,515 shares, compared to its average volume of 54,902. Santen Pharmaceutical has a one year low of $12.50 and a one year high of $20.93. The company’s fifty day moving average is $14.40 and its 200-day moving average is $13.83.

A number of equities research analysts recently commented on SNPHY shares. Daiwa Capital Markets upgraded shares of Santen Pharmaceutical from an “underperform” rating to a “neutral” rating in a report on Wednesday, July 21st. Mizuho upgraded shares of Santen Pharmaceutical from a “neutral” rating to a “buy” rating in a report on Monday, June 7th.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical Co, Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.

Featured Story: Dual Listing

Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with's FREE daily email newsletter.